Protagenic Therapeutics, Inc.\new Debt Instrument, Interest Rate, Stated Percentage
Protagenic Therapeutics, Inc.\new (PTIX) had Debt Instrument, Interest Rate, Stated Percentage of 0.00% as of 2015-12-09, per its 10-Q filed 2016-03-11.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2016-03-11
- 2015-12-09: Debt Instrument, Interest Rate, Stated Percentage 0.00%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2015-12-09 | 0.00% 10-Q · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |